| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | ||
|---|---|---|---|---|---|---|
Expenses: | ||||||
Revenue | ||||||
- | - | - | 0 | 0 | ||
Research and development | ||||||
16,835 | 18,733 | 6,274 | 7,834 | 4,865 | ||
General and administrative | ||||||
10,022 | 10,374 | 5,552 | 6,439 | 7,992 | ||
Operating expenses | ||||||
26,857 | 29,107 | 11,826 | - | - | ||
Other income (expense): | ||||||
Interest income | ||||||
574 | 283 | 68 | - | - | ||
Foreign exchange gains/( losses) | ||||||
6 | -44 | 115 | - | - | ||
Total other income | ||||||
580 | 239 | 183 | - | - | ||
Net loss | ||||||
-26,277 | -28,868 | -11,643 | - | - | ||
Other comprehensive loss: | ||||||
Unrealized gain/(loss) on securities available-for-sale | ||||||
18 | - | -18 | - | - | ||
Total comprehensive loss | ||||||
-26,259 | -28,868 | -11,661 | - | - | ||
Basic and diluted loss per common share (in dollars per share) | ||||||
-0.52 | -0.86 | -0.52 | - | - | ||
Weighted average number of common shares outstanding used in the calculation of (in thousands) Basic and diluted loss per common share (in shares) | ||||||
50,160 | 33,391 | 22,313 | - | - | ||
Operating Expenses | ||||||
- | - | - | 14,273 | 12,857 | ||
Finance expense (note 9) | ||||||
- | - | - | 46 | 34 | ||
Finance income (note 9) | ||||||
- | - | - | 79 | 1,180 | ||
Net finance income | ||||||
- | - | - | 33 | 1,146 | ||
Net loss and comprehensive loss for the period | ||||||
- | - | - | -14,240 | -11,711 | ||
Translation adjustment | ||||||
- | - | - | 485 | -3,519 | ||
Comprehensive loss for the year | ||||||
- | - | - | -13,755 | -15,230 | ||
Basic and diluted loss per common share (in dollars per share) | ||||||
- | - | - | -1.12 | -0.98 | ||
Weighted average number of common shares outstanding used in the calculation of basic and diluted loss per common share (000s) note 6(b) (in shares) | ||||||
- | - | - | 12,743 | 11,906 | ||